Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan in Hemodialysis Patients with Heart Failure
NCT04458285Unknown
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Jan 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of sacubitril + valsartan in heart failure (HF) (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Left Ventricular Ejection Fraction at 12 weeks. Status: unknown.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT04458285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04458285.